Effect of automated breast volume scanner (ABVS) census on HAMA and HAMD scores of patients with breast hyperplastic nodules smaller than 1 cm

Objective: To investigate the effect of automated breast volume scanner (ABVS) census on the quality of life of the patients with breast hyperplastic nodules < 1 cm. Materials and Methods: From March 2014 to February 2016, 1,366 subjects were screened in the Fourth Hospital of Shijiazhuang. Hamilton Anxiety Scale (HAMA) and Hamilton Rating Scale for Depression (HAMD) were compared between the subjects received ABVS and those received color Doppler ultrasound. Then the 289 patients with breast hyperplastic nodules < 1 cm were divided into groups according to the different clinical manifestations and surgical methods to compare their HAMA and HAMD scores. Results: There were significant differences in HAMA and HAMD scores between the subjects received color Doppler ultrasound and those receiving ABVS examination (p < 0.05). HAMA and HAMD scores were also statistically different (p < 0.05) in terms of the different clinical manifestations and surgical methods. Conclusion: ABVS examination can detect early-stage of hyperplastic nodules more accurately the conventional color Doppler ultrasound and guide the patients for further treatment.

ABVS census; Breast hyperplastic Nodules < 1 cm; HAMA and HAMD scores; Clinical intervention.

[1] Cavalieri E.L., Rogan E.G., Zahid M.: “Critical depurinating DNA adducts: Estrogen adducts in the etiology and prevention of cancer and dopamine adducts in the etiology and prevention of Parkinson’s disease”. Int. J. Cancer, 2017, 141, 1078.

[2] Houssami N., Turner R.M., Morrow M.: “Meta-analysis of pre-op-erative magnetic resonance imaging (MRI) and surgical treatment for breast cancer”. Breast Cancer Res. Treat., 2017, 165, 273.

[3] Narkhede A.A., Shevde L.A., Rao S.S.: “Biomimetic strategies to recapitulate organ specific microenvironments for studying breast cancer metastasis”. Int. J. Cancer, 2017, 141, 1091.

[4] van den Ende C., Oordt-Speets A.M., Vroling H., van Agt H.M.E.: “Benefits and harms of breast cancer screening with mammography in women aged 40-49 years: A systematic review”. Int. J. Cancer, 2017, 141, 1295.

[5] Welsh J.: “Function of the vitamin D endocrine system in mammary gland and breast cancer”. Mol. Cell Endocrinol., 2017, 453, 88.

[6] Chand A.R., Ziauddin M.F., Tang S.C.: “Can Locoregionally Recur-rent Breast Cancer Be Cured”? Clin. Breast Cancer, 2017, 17, 326.

[7] Gernaat S.A.M., Ho P.J., Rijnberg N., Emaus M.J., Baak L.M., Hart-man M., et al.: “Risk of death from cardiovascular disease following breast cancer: a systematic review”. Breast Cancer Res. Treat., 2017, 164, 537.

[8] Ngeow J., Sesock K., Eng C.: “Breast cancer risk and clinical impli-cations for germline PTEN mutation carriers”. Breast Cancer Res. Treat., 2017, 165, 1.

[9] Ruddy K.J., Van Houten H.K., Sangaralingham L.R., Freedman R. A., Thompson C.A., Hashmi S.K., et al.: “Impact of treatment reg-imen on acute care use during and after adjuvant chemotherapy for early-stage breast cancer”. Breast Cancer Res. Treat., 2017, 164, 515.

[10] Meng Z., Chen C., Zhu Y., Zhang S., Wei C., Hu B., et al.: “Diag-nostic performance of the automated breast volume scanner: a sys-tematic review of inter-rater reliability/agreement and meta-analysis of diagnostic accuracy for differentiating benign and malignant breast lesions”. Eur. Radiol., 2015, 25, 3638.

[11] Wöhrle N.K., Hellerhoff K., Notohamiprodjo M., Reiser M.F., Clev-ert D.A.: “Automated breast volume scanner (ABVS): a new ap-proach for breast imaging”. Radiologe, 2010, 50, 973.

[12] Yun S.J., Ryu C.W., Rhee S.J., Ryu J.K., Oh J.Y.: “Benefit of adding digital breast tomosynthesis to digital mammography for breast can-cer screening focused on cancer characteristics: a meta-analysis”. Breast Cancer Res. Treat., 2017, 164, 557.

[13] Ferbeyre-Binelfa L., Ramírez-Bollas J., Bautista-Piña V., Espejo-Fonseca R., Ruvalcaba-Limón E., Serratos-Garduño E.: “Fibromato-sis of the breast. Report of two cases and review of the literature”. Cir. Cir., 2009, 77, 313.

[14] Bok S.K., Jeon Y., Hwang P.S.: “Ultrasonographic Evaluation of the Effects of Progressive Resistive Exercise in Breast Cancer-Related Lymphedema”. Lymphat. Res. Biol., 2016, 14, 18.

[15] Emren S.V., Tuluce S.Y., Levent F., Tuluce K., Kalkan T., Yildiz Y. et al.: “Evaluation of Trastuzumab-induced early cardiac dysfunction using two-dimensional Strain Echocardiography”. Med. Ultrason., 2015, 17, 496.

[16] Abdullah M.M., Mohamed A.K., Foo Y.C., Lee C.M., Chua C.T., Wu C.H. et al.: “Breast Cancer Survival at a Leading Cancer Centre in Malaysia”. Asian Pac. J. Cancer Prev., 2015, 16, 8513.

[17] Stagl J.M., Lechner S.C., Carver C.S., Bouchard L.C., Gudenkauf L. M., Jutagir D.R., et al.: “A randomized controlled trial of cogni-tive-behavioral stress management in breast cancer: survival and re-currence at 11-year follow-up”. Breast Cancer Res. Treat., 2015, 154, 319.

[18] Schapira M.M., Mackenzie E.R., Lam R., Casarett D., Seluzicki C. M., Barg F.K. et al.: “Breast cancer survivors willingness to par-ticipate in an acupuncture clinical trial: a qualitative study”. Support. Care Cancer, 2014, 22, 1207.

[19] Shen S., Zhou Y., Xu Y., Zhang B., Duan X., Huang R., et al.: “A multi-centre randomised trial comparing ultrasound vs mammogra-phy for screening breast cancer in high-risk Chinese women”. Br. J. Cancer, 2015, 112, 998.

[20] Land S.R., Liu Q., Wickerham D.L., Costantino J.P., Ganz P.A.: “Cigarette smoking, physical activity, and alcohol consumption as predictors of cancer incidence among women at high risk of breast cancer in the NSABP P-1 trial”. Cancer Epidemiol. Biomarkers Prev., 2014, 23, 823.

[21] Lumachi F., Basso S.M., Santeufemia D.A., Bonamini M., Chiara G. B.: “Ultrasonic dissection system technology in breast cancer: a case-control study in a large cohort of patients requiring axillary dis-section”. Breast Cancer Res. Treat., 2013, 142, 399.

[22] Li M.H., Liu Y., Liu L.S., Li P.X., Chen Q.: “Differential diagnostic value of real-time tissue elastography and three dimensional ultra-sound imaging in breast lumps”. Zhonghua Yi Xue Za Zhi, 2016, 96, 1515.

[23] Neuhouser M.L., Aragaki A.K., Prentice R.L., Manson J.E., Chle-bowski R., Carty C.L., et al.:"Overweight, Obesity, and Post-menopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women’s Health Initiative Randomized Clinical Trials". JAMA Oncol., 2015, 1, 611.